slotkoers
Shenzhen S.E.
00:00:00 15-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5,03
CNY
|
-1,57%
|
|
-8,21%
|
-29,35%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
3.423
|
4.447
|
4.727
|
4.523
|
3.208
|
3.503
|
Bedrijfswaarde
1 |
3.232
|
4.199
|
4.417
|
4.204
|
3.088
|
3.545
|
K/w-verhouding
|
23,3
x
|
12,8
x
|
26,6
x
|
36,7
x
|
326
x
|
-47,5
x
|
Dividendrendement
|
1,43%
|
0,78%
|
0,63%
|
0,76%
|
1,07%
|
-
|
Marktkapitalisatie/omzet
|
5,63
x
|
5,43
x
|
5,71
x
|
5,36
x
|
4,19
x
|
3,93
x
|
Bedrijfswaarde/omzet
|
5,32
x
|
5,13
x
|
5,34
x
|
4,98
x
|
4,03
x
|
3,98
x
|
Bedrijfswaarde/EBITDA
|
20,5
x
|
20,6
x
|
24,6
x
|
24,2
x
|
44,7
x
|
150
x
|
Bedrijfswaarde/FCF
|
56,3
x
|
35,7
x
|
-1.039
x
|
-34,3
x
|
-52,9
x
|
-20,1
x
|
FCF Yield
|
1,78%
|
2,8%
|
-0,1%
|
-2,92%
|
-1,89%
|
-4,97%
|
Price to Book
|
2,84
x
|
3,07
x
|
2,71
x
|
2,44
x
|
1,81
x
|
2,12
x
|
Aantal aandelen (in duizenden)
|
488.990
|
494.690
|
494.494
|
492.718
|
491.956
|
491.935
|
Referentieprijs
2 |
7,000
|
8,990
|
9,560
|
9,180
|
6,520
|
7,120
|
Datum van publicatie
|
27/02/19
|
11/03/20
|
18/03/21
|
29/03/22
|
23/04/23
|
21/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
608,1
|
819,1
|
827,3
|
843,9
|
765,9
|
890,7
|
EBITDA
1 |
157,8
|
203,8
|
179,7
|
173,6
|
69,09
|
23,6
|
Bedrijfsresultaat (EBIT)
1 |
140,5
|
183,2
|
137,3
|
111,4
|
-5,124
|
-56,82
|
Operationele Marge
|
23,1%
|
22,37%
|
16,6%
|
13,2%
|
-0,67%
|
-6,38%
|
Resultaat voor belastingen (EBT)
1 |
164,9
|
396,8
|
173,8
|
121
|
-14,76
|
-101,2
|
Nettowinst (verlies)
1 |
147,8
|
342,4
|
174,7
|
125
|
11,21
|
-71,76
|
Nettomarge
|
24,3%
|
41,81%
|
21,12%
|
14,81%
|
1,46%
|
-8,06%
|
WPA
2 |
0,3000
|
0,7000
|
0,3600
|
0,2500
|
0,0200
|
-0,1500
|
Free Cash Flow
1 |
57,38
|
117,7
|
-4,251
|
-122,6
|
-58,31
|
-176,1
|
FCF-marge
|
9,44%
|
14,38%
|
-0,51%
|
-14,53%
|
-7,61%
|
-19,77%
|
Kasstroomconversie (ebitda)
|
36,35%
|
57,78%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
38,83%
|
34,39%
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,1000
|
0,0700
|
0,0600
|
0,0700
|
0,0700
|
-
|
Datum van publicatie
|
27/02/19
|
11/03/20
|
18/03/21
|
29/03/22
|
23/04/23
|
21/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
42,3
|
Nettokaspositie
1 |
191
|
248
|
311
|
319
|
120
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
1,792
x
|
Free Cash Flow
1 |
57,4
|
118
|
-4,25
|
-123
|
-58,3
|
-176
|
ROE (netto-inkomsten/eigen vermogen)
|
13%
|
25,8%
|
9,21%
|
5,48%
|
-0,23%
|
-4,49%
|
ROA (netto-inkomsten/totale activa)
|
7,23%
|
7,86%
|
3,84%
|
2,42%
|
-0,11%
|
-1,26%
|
Totale activa
1 |
2.044
|
4.355
|
4.551
|
5.160
|
-10.015
|
5.696
|
Nettoactief per aandeel
2 |
2,470
|
2,930
|
3,520
|
3,770
|
3,610
|
3,360
|
Cashflow per aandeel
2 |
0,3900
|
0,5000
|
2,050
|
1,820
|
1,560
|
1,520
|
Capex
1 |
54,1
|
35
|
172
|
148
|
103
|
145
|
Capex/omzet
|
8,89%
|
4,27%
|
20,8%
|
17,51%
|
13,42%
|
16,24%
|
Datum van publicatie
|
27/02/19
|
11/03/20
|
18/03/21
|
29/03/22
|
23/04/23
|
21/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -29,35% | 348 mln. | | +31,37% | 588 mld. | | -2,60% | 364 mld. | | +20,83% | 326 mld. | | +5,69% | 285 mld. | | +14,83% | 239 mld. | | +9,93% | 210 mld. | | -6,95% | 200 mld. | | +10,77% | 167 mld. | | +0,10% | 161 mld. |
Farmaceutische producten - Andere
|